These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


470 related items for PubMed ID: 29299635

  • 21. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
    Yukita A, Hosoya A, Ito Y, Katagiri T, Asashima M, Nakamura H.
    Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
    [Abstract] [Full Text] [Related]

  • 22. Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance.
    Schultheis J, Beckmann D, Mulac D, Müller L, Esselen M, Düfer M.
    Oxid Med Cell Longev; 2019 May; 2019():7518510. PubMed ID: 31827698
    [Abstract] [Full Text] [Related]

  • 23. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
    Kim ET, Kim KK, Matunis MJ, Ahn JH.
    Biochem Biophys Res Commun; 2009 Oct 09; 388(1):41-5. PubMed ID: 19635459
    [Abstract] [Full Text] [Related]

  • 24. Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells.
    Chen S, Han J, Liu Y.
    PLoS One; 2015 Oct 09; 10(9):e0137583. PubMed ID: 26335571
    [Abstract] [Full Text] [Related]

  • 25. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL, Kuo HY, Chang CC, Naik MT, Liao PH, Ho CC, Huang TC, Jeng JC, Hsu PH, Tsai MD, Huang TH, Shih HM.
    EMBO J; 2013 Mar 20; 32(6):791-804. PubMed ID: 23395904
    [Abstract] [Full Text] [Related]

  • 26. Activated PKR inhibits pancreatic β-cell proliferation through sumoylation-dependent stabilization of P53.
    Song Y, Wan X, Gao L, Pan Y, Xie W, Wang H, Guo J.
    Mol Immunol; 2015 Dec 20; 68(2 Pt A):341-9. PubMed ID: 26446704
    [Abstract] [Full Text] [Related]

  • 27. SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.
    Tomasi ML, Ramani K, Ryoo M, Cossu C, Floris A, Murray BJ, Iglesias-Ara A, Spissu Y, Mavila N.
    FASEB J; 2018 Jun 20; 32(6):3278-3288. PubMed ID: 29401608
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
    Chang YL, Huang CJ, Chan JY, Liu PY, Chang HP, Huang SM.
    Int J Biochem Cell Biol; 2007 Jun 20; 39(5):1035-46. PubMed ID: 17336575
    [Abstract] [Full Text] [Related]

  • 30. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E, Tozluoğlu M, Nussinov R, Haliloğlu T.
    J Mol Biol; 2011 Mar 04; 406(4):620-30. PubMed ID: 21216249
    [Abstract] [Full Text] [Related]

  • 31. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice.
    Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, Jouvion G, Bomme P, Hamard G, Romagnolo B, Terris B, Cumano A, Barker N, Clevers H, Dejean A.
    Gastroenterology; 2011 Jan 04; 140(1):286-96. PubMed ID: 20951138
    [Abstract] [Full Text] [Related]

  • 32. FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells.
    Wang CM, Yang WH, Liu R, Wang L, Yang WH.
    Int J Mol Sci; 2018 Jul 13; 19(7):. PubMed ID: 30011797
    [Abstract] [Full Text] [Related]

  • 33. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases.
    Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, Patel VS, Rudic RD, Stepp DW, Fulton DJ.
    Arterioscler Thromb Vasc Biol; 2011 Jul 13; 31(7):1634-42. PubMed ID: 21527745
    [Abstract] [Full Text] [Related]

  • 34. Interaction between Brucella melitensis 16M and small ubiquitin-related modifier 1 and E2 conjugating enzyme 9 in mouse RAW264.7 macrophages.
    Yi J, Wang Y, Li Q, Zhang H, Shao Z, Deng X, He J, Xiao C, Wang Z, Wang Y, Chen C.
    J Vet Sci; 2019 Sep 13; 20(5):e54. PubMed ID: 31565897
    [Abstract] [Full Text] [Related]

  • 35. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models.
    Verma DK, Ghosh A, Ruggiero L, Cartier E, Janezic E, Williams D, Jung EG, Moore M, Seo JB, Kim YH.
    eNeuro; 2020 Sep 13; 7(5):. PubMed ID: 32887693
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
    Huang CH, Yang TT, Lin KI.
    J Biomed Sci; 2024 Jan 27; 31(1):16. PubMed ID: 38280996
    [Abstract] [Full Text] [Related]

  • 37. UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae.
    Ho CW, Chen HT, Hwang J.
    J Biol Chem; 2011 Jun 17; 286(24):21826-34. PubMed ID: 21518767
    [Abstract] [Full Text] [Related]

  • 38. Targeting Ubc9 for cancer therapy.
    Mo YY, Moschos SJ.
    Expert Opin Ther Targets; 2005 Dec 17; 9(6):1203-16. PubMed ID: 16300471
    [Abstract] [Full Text] [Related]

  • 39. SUMO-Modification of Human Nrf2 at K110 and K533 Regulates Its Nucleocytoplasmic Localization, Stability and Transcriptional Activity.
    Walters TS, McIntosh DJ, Ingram SM, Tillery L, Motley ED, Arinze IJ, Misra S.
    Cell Physiol Biochem; 2021 Mar 27; 55(2):141-159. PubMed ID: 33770425
    [Abstract] [Full Text] [Related]

  • 40. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
    Ying S, Dünnebier T, Si J, Hamann U.
    PLoS One; 2013 Mar 27; 8(9):e75695. PubMed ID: 24086615
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.